story of the week
The BRCA1ness Signature Is Associated Significantly With Response to PARP Inhibitors in the I-SPY 2 Randomized Neoadjuvant Setting
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The BRCA1ness Signature Is Associated Significantly With Response to PARP Inhibitor Treatment Versus Control in the I-SPY 2 Randomized Neoadjuvant Setting
Breast Cancer Res 2017 Aug 25;[EPub Ahead of Print], TM Severson, DM Wolf, C Yau, J Peeters, D Wehkam, PC Schouten, SF Chin, IJ Majewski, M Michaut, A Bosma, B Pereira, T Bismeijer, L Wessels, C Caldas, R Bernards, IM Simon, AM Glas, S Linn, L van 't VeerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.